Skip to content

Sera Prognostics SERA Book value per share

Book value per share at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$3.60-53.3%
Quest Diagnostics logo
Quest DiagnosticsDGX
$65.77+7.3%
Natera, Inc. logo
Natera, Inc.NTRA
$12.54+36.3%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$9.53+139%
Revvity logo
RevvityRVTY
$64.20+1.1%
Personalis, Inc. logo
Personalis, Inc.PSNL
$2.45+3.1%

Other financials

Income statement

See full
Revenue$14.0K-63.2%
Operating income-$9.4M-1.2%
Net income-$8.4M-2.6%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$4.2M-20.2%
Total debt$2.5M+286%
Total equity$67.6M-28.7%
Total assets$93.5M-20.8%

Cash flow

See full
Operating cash flow-$8.8M-16.2%
CapEx$8.0K+167%
Free cash flow-$8.8M-16.2%

Valuation

See full
Market cap$71.27M+5.0%
Enterprise value$69.6M+9.6%
P/S1,250.3×+622×

Profitability

See full
Operating margin-64,235.1%-8,092,342pp
Net margin-56,386%+1,586,573pp
FCF margin-48,377.2%-673,104pp

Returns & leverage

See full
Return on equity-39.6%-1.6pp
Debt / equity0.0×
Current ratio2.1×+0.1×

Where this comes from

Calculated from Sera Prognostics’s reported figures.

Based on the most recent quarter.

The official record: Sera Prognostics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sera Prognostics's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sera Prognostics's book value per share?
Sera Prognostics (SERA) reported book value per share of $1.35 in Q1 2026.
How has Sera Prognostics's book value per share changed year-over-year?
Sera Prognostics's book value per share decreased by 40.4% year-over-year, from $2.26 to $1.35.
What is the long-term trend for Sera Prognostics's book value per share?
Over 5 years (2020 to 2025), Sera Prognostics's book value per share has grown at a -54.5% compound annual growth rate (CAGR), from -$80.71 to $1.58.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.